Standalone PFA for complex macro-reentrant and fibrillatory substrates following Mustard-atrial switch
item.page.dc.date.issued
2026-01-01
item.page.dc.type
item.page.dc.identifier.issn
25901753
item.page.dc.identifier.eissn
09726292
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105049086088
item.page.oaire.citation.title
Indian Pacing and Electrophysiology Journal
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Indian Pacing and Electrophysiology Journal (2026)
punsarn.item.page.citation
Kulthamrongsri N., Mohpichai N., Rattanawong P., Prasitlumkum N. Standalone PFA for complex macro-reentrant and fibrillatory substrates following Mustard-atrial switch. Indian Pacing and Electrophysiology Journal (2026). doi:10.1016/j.ipej.2026.08.005 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/118543
item.page.dc.title
Standalone PFA for complex macro-reentrant and fibrillatory substrates following Mustard-atrial switch
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
The emergence of pulsed field ablation (PFA) has revolutionized atrial arrhythmia (AA) ablation practice, mainly in adults with normal structural hearts. Little is known about its applicability in adults with CHD. A 41-year-old male with d-transposition of the great arteries (d-TGA) status post Mustard procedure, with longstanding atrial arrhythmia and multiple prior ablations, presented with recurrent symptomatic AA refractory to medical therapy. Endocardial AA ablation was performed using a standalone PFA-based approach. Following comprehensive bilateral atrial mapping, a critical isthmus was identified along a prior incisional scar related to the interatrial baffle, consistent with incisional atrial flutter. Immediate termination was achieved following the first PFA delivery using a pentaspline catheter (FARAWAVE, Boston Scientific). Additional scar homogenization was delineated entirely with only PFA. The patient has remained clinically free from AA at 4-month follow-up. This case underscores the novelty and potential applicability of a standalone PFA approach not only in patients with normal cardiac structure, but also in adults with CHD.
